Bruker (TICKER: BRKR) Benchmark And Performance Data

there are 11 of samples in the benchmark for Bruker in year 2022 in 2022. The total inventory for Bruker was $710,100,000.00 in 2021. The total inventory for Bruker was $692,300,000.00 in 2020. The total inventory for Bruker was $611,500,000.00 in 2012. The total inventory for Bruker was $589,800,000.00 in 2013. The total inventory for Bruker was $577,200,000.00 in 2019. The total inventory for Bruker was $509,600,000.00 in 2018. The total inventory for Bruker was $486,200,000.00 in 2017. The total inventory for Bruker was $477,400,000.00 in 2014. The total inventory for Bruker was $440,400,000.00 in 2016. The total inventory for Bruker was $422,000,000.00 in 2015. The sales, general, and administrative (SGA) for Bruker was $564,500,000.00 in 2021. The sales, general, and administrative (SGA) for Bruker was $504,800,000.00 in 2019. The sales, general, and administrative (SGA) for Bruker was $477,800,000.00 in 2020. The sales, general, and administrative (SGA) for Bruker was $454,200,000.00 in 2014. The sales, general, and administrative (SGA) for Bruker was $453,100,000.00 in 2018. The sales, general, and administrative (SGA) for Bruker was $444,000,000.00 in 2013. The sales, general, and administrative (SGA) for Bruker was $440,400,000.00 in 2012. The sales, general, and administrative (SGA) for Bruker was $420,200,000.00 in 2017. The sales, general, and administrative (SGA) for Bruker was $402,800,000.00 in 2015. The sales, general, and administrative (SGA) for Bruker was $394,400,000.00 in 2016. The sales, general, and administrative (SGA) for Bruker was $$611,000,000 in 2022. The revenue volatility for Bruker was 11.40% in 2022. The market capitalization for Bruker was $9,599,456,438.00 in 2015. The market capitalization for Bruker was $9,308,806,834.00 in 2016. The market capitalization for Bruker was $9,148,948,254.00 in 2021. The market capitalization for Bruker was $7,819,273,600.00 in 2017. The market capitalization for Bruker was $12,649,741,876.00 in 2014. The market capitalization for Bruker was $11,847,040,858.00 in 2013. The market capitalization for Bruker was $11,570,656,634.00 in 2019. The market capitalization for Bruker was $11,477,118,782.00 in 2012. The market capitalization for Bruker was $10,852,718,184.00 in 2020. The market capitalization for Bruker was $10,053,104,185.00 in 2018. The market capitalization for Bruker was $$9,896,000,000 in 2022. The gross revenue for Bruker was $2,417,900,000.00 in 2021. The gross revenue for Bruker was $2,072,600,000.00 in 2019. The gross revenue for Bruker was $1,987,500,000.00 in 2020. The gross revenue for Bruker was $1,895,600,000.00 in 2018. The gross revenue for Bruker was $1,839,400,000.00 in 2013. The gross revenue for Bruker was $1,808,900,000.00 in 2014. The gross revenue for Bruker was $1,791,400,000.00 in 2012. The gross revenue for Bruker was $1,765,900,000.00 in 2017. The gross revenue for Bruker was $1,623,800,000.00 in 2015. The gross revenue for Bruker was $1,611,300,000.00 in 2016. The gross revenue for Bruker was $$2,531,000,000 in 2022. The gross margin for Bruker was $18.02% in 2022. The days sales outstanding for Bruker was 64 days in 2022. The days payable outstanding for Bruker was 49 days in 2022. The days of inventory for Bruker was $225 in 2022. The cost of goods sold (COGS) for Bruker was 48.41% in 2022. The cost of goods sold (COGS) for Bruker was $995,600,000.00 in 2018. The cost of goods sold (COGS) for Bruker was $962,000,000.00 in 2012. The cost of goods sold (COGS) for Bruker was $949,900,000.00 in 2017. The cost of goods sold (COGS) for Bruker was $915,200,000.00 in 2015. The cost of goods sold (COGS) for Bruker was $866,000,000.00 in 2016. The cost of goods sold (COGS) for Bruker was $1,208,300,000.00 in 2021. The cost of goods sold (COGS) for Bruker was $1,077,300,000.00 in 2019. The cost of goods sold (COGS) for Bruker was $1,047,700,000.00 in 2020. The cost of goods sold (COGS) for Bruker was $1,045,600,000.00 in 2014. The cost of goods sold (COGS) for Bruker was $1,034,200,000.00 in 2013. The cost of goods sold (COGS) for Bruker was $$1,225,000,000 in 2022. The cash to cash cycle time for Bruker was 240 in 2022. The annual percentage growth rate of Bruker was -0.05% in 2022. Bruker in its benchmark peer group, had rank 9 for cash to cash cycle time in 2022. Bruker in its benchmark peer group, had rank 9 days for days of inventory in 2022. Bruker in its benchmark peer group, had rank 7 days for days sales outstanding in 2022. Bruker in its benchmark peer group, had rank 6 for sales growth in 2022. Bruker in its benchmark peer group, had rank 11 for gross revenue in 2022. Bruker in its benchmark peer group, had rank 10 for cost of goods sold as a percent of revenue in 2022. Bruker headquarters region is East. Bruker has ticker symbol BRKR. Bruker has the following profile: Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies.. Bruker has primary indstury Medical Devices. Bruker had a $$1,204,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Bruker had Abbott Laboratories, and QuidelOrtho, and Zimmer Biomet, and Edwards Lifesciences, and Bio-Rad Laboratories, and Boston Scientific, and Align Technology, and Stryker, and AdaptHealth, and Bruker, and DexCom benchmark peer companies for its SIC code in 2022. Bruker had 8,525 number of employees in 2022. Bruker had 66 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Bruker had 4 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Bruker had 11.98% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Bruker had 11.16% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Bruker had 102 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Bruker had 1.51% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Bruker had 0.03% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Bruker can reduce overall cost by $$412,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Bruker can reduce inventory with practices including SKU Reduction in 2022. Bruker can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Bruker can reduce inventory with practices including Forecast Accuracy in 2022. Bruker can reduce inventory with practices including Demand Shaping in 2022. Bruker can reduce days sales outstanding with practices including in 2022. Bruker can increase sales revenue by $$1,204,000,000 improving sales performance to next benchmark tier in 2022. Bruker can increase revenue growth by $$1,000,000 by improving growth performance to next benchmark tier in 2022. Bruker can increase overall revenue by $$1,205,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Bruker can increase days payables outstanding with practices including Strategic Sourcing in 2022. Bruker can increase days payables outstanding by $76,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. Bruker can improve total financial performance by $$2,178,000,000 by improving revenue, costs, and working capital in 2022. Bruker can decrease overall working capital by $$562,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Bruker can decrease inventory days by $458,000,000 days by reducing inventory days to next benchmark tier in 2022. Bruker can decrease days sales outstanding by $28,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Bruker can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Bruker can accelerate revenue growth practices including Pricing Optimization in 2022. Bruker can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 94 days was the measured superior or top ten performance level for days of inventory in Bruker's peer group in 2022. 9.89% was the measured superior or top ten performance level for sales volatility in Bruker's peer group in 2022. 75 days was the measured superior or top ten performance level for cash to cash cycle time in Bruker's peer group in 2022. 60 days was the measured parity or middle performance level for days sales outstanding in Bruker's peer group in 2022. 53 days was the measured advantage or top third performance level for days sales outstanding in Bruker's peer group in 2022. 44 days was the measured superior or top ten performance level for days sales outstanding in Bruker's peer group in 2022. 37.24% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Bruker's peer group in 2022. 31.56% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Bruker's peer group in 2022. 30.00% was the measured superior or top ten performance level for gross margin in Bruker's peer group in 2022. 29.10% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Bruker's peer group in 2022. 159 days was the measured parity or middle performance level for days of inventory in Bruker's peer group in 2022. 138 days was the measured parity or middle performance level for cash to cash cycle time in Bruker's peer group in 2022. 13.32% was the measured parity or middle performance level for sales volatility in Bruker's peer group in 2022. 119 days was the measured advantage or top third performance level for cash to cash cycle time in Bruker's peer group in 2022. 11.40% was the measured advantage or top third performance level for sales volatility in Bruker's peer group in 2022. 108 days was the measured advantage or top third performance level for days of inventory in Bruker's peer group in 2022. 0.04% was the measured superior or top ten performance level for sales growth in Bruker's peer group in 2022. -0.05% was the measured parity or middle performance level for sales growth in Bruker's peer group in 2022. -0.02% was the measured advantage or top third performance level for sales growth in Bruker's peer group in 2022. $18.02% was the measured advantage or top third performance level for gross margin in Bruker's peer group in 2022. $17.18% was the measured parity or middle performance level for gross margin in Bruker's peer group in 2022. $$6,940,000,000 was the measured advantage or top third performance level for gross revenue in Bruker's peer group. $$3,735,000,000 was the measured parity or middle performance level for gross revenue in Bruker's peer group in 2022. $$18,449,000,000 was the measured superior or top ten performance level for gross revenue in Bruker's peer group in 2022.